Back to Walleye Capital LLC Walleye Capital LLC

DRUGDRUG
7 quarters

Position history for Walleye Capital LLCWalleye Capital LLC's holdings in BRIGHT MINDS BIOSCIENCES INC

Walleye Capital LLC holds 66,106 shares of DRUG (BRIGHT MINDS BIOSCIENCES INC), worth $4.6M as of 2026-Q2. The position was increased (+23.1% shares). DRUG represents 0.0% of Walleye Capital LLC's portfolio.

Current Value

$4.6M

Current Shares

66,106

Total Value Change

+$923,665

Total Shares Change

-37,086

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
66,106
+23.1%
$4.6M0.0%$70.20
33
2026-Q1
Increased
53,706
+108.0%
$3.9M0.0%$80.00
43
2025-Q4
Decreased
25,826
-64.5%
$2M0.0%$75.85
0
2025-Q3
Increased
72,754
+36.2%
$4.4M0.0%$57.45
35
2025-Q2
Decreased
53,430
-37.2%
$1.4M0.0%$23.27
0
2025-Q1
Decreased
85,022
-17.6%
$3.1M0.0%$36.50
0
2024-Q4
New
103,192
-
$3.7M0.0%$36.86
37

Other major holders of DRUG: Jupiter Topco LLC, Janus Henderson Group Ltd., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used